Top

Published in:

01-06-2021 | Cushing's Syndrome | Case Report

Multiple vertebral compression fractures in a human immunodeficiency virus-positive patient with glucocorticoid-induced Cushing syndrome treated with percutaneous vertebroplasty: a case report

Authors: H.-E. Hsu, Y.-P. Hsu, C.-H. Yu

Published in: Osteoporosis International | Issue 6/2021

Abstract

The authors present a rare case of multiple vertebral compression fractures in a young female with iatrogenic glucocorticoid-induced Cushing syndrome and concomitant human immunodeficiency virus (HIV) infection. Both long-term steroid use and HIV infection may lead to osteopenia or even osteoporosis. Multiple vertebral fractures in young patients are very uncommon and should alert the examiner to investigate any underlying cause. Treatment choices include pharmacological agents such as bisphosphonates or parathyroid hormone and even surgical interventions such as percutaneous vertebroplasty.

Available only for authorised users

Wong SPY, Mok CC (2020) Management of glucocorticoid-related osteoporotic vertebral fracture. Osteoporos Sarcopenia. 6(1):1–7CrossRef

Adami G, Saag KG (2019) Glucocorticoid-induced osteoporosis update. Curr Opin Rheumatol. 31(4):388–393CrossRef

van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 13(10):777–787CrossRef

LeBlanc CM, Ma J, Taljaard M et al (2015) Incident vertebral fractures and risk factors in the first three years following glucocorticoid initiation among pediatric patients with rheumatic disorders. J Bone Miner Res. 30(9):1667–1675CrossRef

Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, Humphrey MB, Lane NE, Magrey M, Miller M, Morrison L, Rao M, Byun Robinson A, Saha S, Wolver S, Bannuru RR, Vaysbrot E, Osani M, Turgunbaev M, Miller AS, McAlindon T (2017) 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Care Res (Hoboken). 69(8):1095–1110CrossRef

Compston J, Cooper A, Cooper C et al (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 12(1):43CrossRef

Lekamwasam S, Adachi JD, Agnusdei D et al (2012) A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int. 23(9):2257–2276CrossRef

Saag KG, Shane E, Boonen S, Marín F, Donley DW, Taylor KA, Dalsky GP, Marcus R (2007) Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med. 357(20):2028–2039CrossRef

Balasubramanian A, Wade SW, Adler RA, Lin CJF, Maricic M, O’Malley CD, Saag K, Curtis JR (2016) Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis. Osteoporos Int. 27(11):3239–3249CrossRef

10.

Walker Harris V, Brown TT (2012) Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies. J Infect Dis 205(Suppl 3):S391–S398CrossRef

11.

Brown TT, McComsey GA, King MS, Qaqish RB, Bernstein BM, da Silva BA (2009) Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen. J Acquir Immune Defic Syndr. 51(5):554–561CrossRef

12.

Grant PM, Kitch D, McComsey GA et al (2013) Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation. Clin Infect Dis. 57(10):1483–1488CrossRef

13.

Brown TT, Moser C, Currier JS, Ribaudo HJ, Rothenberg J, Kelesidis T, Yang O, Dubé MP, Murphy RL, Stein JH, McComsey GA (2020) Erratum to: Changes in bone mineral density after initiation of antiretroviral treatment with tenofovir disoproxil fumarate/emtricitabine plus atazanavir/ritonavir, darunavir/ritonavir, or raltegravir. J Infect Dis. 221(12):2083–2084CrossRef

14.

Elliot ER, Theodoraki A, Jain LR, Marshall NJ, Boffito M, Baldeweg SE, Waters LJ (2016) Iatrogenic Cushing’s syndrome due to drug interaction between glucocorticoids and the ritonavir or cobicistat containing HIV therapies. Clin Med (Lond). 16(5):412–418CrossRef

15.

Saberi P, Phengrasamy T, Nguyen DP (2013) Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management. HIV Med. 14:519–529CrossRef

16.

Kedem E, Shahar E, Hassoun G, Pollack S (2010) Iatrogenic Cushing’s syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient. J Asthma. 47:830–831CrossRef

17.

Yombi JC, Maiter D, Belkhir L et al (2008) Iatrogenic Cushing’s syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavir. Clin Rheumatol 27(Suppl 2):S79–S82CrossRef

18.

Schwarze-Zander C, Klingmuller D, Klumper J et al (2013) Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression: description of a new case and review of the literature. Infection. 41:1183–1187CrossRef

19.

Alidoost M, Conte GA, Agarwal K, Carson MP, Lann D, Marchesani D (2020) Iatrogenic Cushing’s syndrome following intra-articular triamcinolone injection in an HIV-infected patient on cobicistat presenting as a pulmonary embolism: case report and literature review. Int Med Case Rep J. 13:229–235CrossRef

20.

Trout AT, Kallmes DF, Kaufmann TJ (2006) New fractures after vertebroplasty: adjacent fractures occur significantly sooner. AJNR Am J Neuroradiol. 27(1):217–223PubMed

21.

Sun HL, Li CD, Zhu JL et al (2015) Beijing Da Xue Xue Bao Yi Xue Ban. 47(2):242–247PubMed

Title: Multiple vertebral compression fractures in a human immunodeficiency virus-positive patient with glucocorticoid-induced Cushing syndrome treated with percutaneous vertebroplasty: a case report
Authors: H.-E. Hsu
Y.-P. Hsu
C.-H. Yu
Publication date: 01-06-2021
Publisher: Springer London
Keywords: Cushing's Syndrome
Bisphosphonate
Glucocorticoid
Human Immunodeficiency Virus
Osteoporosis
Iatrogenic Cushing's Syndrome
Osteoporosis
Published in: Osteoporosis International / Issue 6/2021
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-021-05880-z

ACC 2024 Congress

Springer Medicine

Multiple vertebral compression fractures in a human immunodeficiency virus-positive patient with glucocorticoid-induced Cushing syndrome treated with percutaneous vertebroplasty: a case report

Abstract

ACC 2024 Congress

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2021

Osteoporosis medication after fracture in older adults: an administrative data analysis

Zoledronic acid reduces the rate of clinical fractures after surgical repair of a hip fracture regardless of the Pretreatment bone mineral density

Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women

Association between body mass index and the risk of falls: a nationwide population-based study

Peri-operative derangement in liver function tests in older patients with neck of femur fracture

Social deprivation predicts adverse health outcomes after hospital admission with hip fracture in England